v3.26.1
Loss before income tax - Summary of Loss Before Income Tax (Details) - USD ($)
$ in Thousands
 12 Months Ended
Jun. 30, 2026
Jun. 30, 2025
Jun. 30, 2024
Disclosure Of Loss Before Income Tax [Abstract]      
Product sales, net $ 115,153 $ 11,263 $ 0
Royalty revenue 5,097 5,935 5,902
Total revenues 120,250 17,198 5,902
Cost of inventories (10,541) (1,193) 0
Amortization of currently marketed intangible assets (6,126) (3,937) 0
Total Cost of revenues (16,667) (5,130) 0
Clinical trial and research & development (30,521) (8,070) (3,308)
Manufacturing production & development (32,693) 6,323 (13,252)
Commercialization (15,869) (4,676) (655)
Employee benefits      
Salaries and employee benefits (28,095) (22,092) (20,415)
Defined contribution superannuation expenses (510) (395) (369)
Equity settled share-based payment transactions (14,873) (22,088) (5,870)
Total Employee benefits (43,478) (44,575) (26,654)
Depreciation and amortization of non-current assets      
Plant and equipment depreciation (481) (303) (410)
Right of use asset depreciation (1,942) (2,139) (2,771)
Right of use asset depreciation (2,340) (2,139)  
Intellectual property amortization (36) (21) (1,485)
Total Depreciation and amortization of non-current assets (2,459) (2,463) (4,666)
Other Selling, general and administration      
Overheads & administration (13,855) (10,168) (8,584)
Consultancy (4,795) (2,728) (2,458)
Legal, patent and other professional fees (6,192) (4,335) (2,342)
Intellectual property expenses (excluding the amount amortized above) (4,993) (3,424) (2,777)
Total Other Selling, general and administration (29,835) (20,655) (16,161)
Fair value remeasurement of contingent consideration      
Remeasurement of financial derivative 7,892 (10,262) 0
Remeasurement of contingent consideration 4,165 (4,625) (9,693)
Total Fair value remeasurement of contingent consideration 12,057 (14,887) (9,693)
Fair value remeasurement of warrant liability      
Remeasurement of warrant liability 859 (4,962) 779
Total Fair value remeasurement of warrant liability 859 (4,962) 779
Other operating income and expenses      
Interest income 3,914 3,554 1,824
Research and development tax incentive income 0 82 859
Government grant revenue 22 3 0
Foreign exchange gains/(losses) 1,069 (106) (76)
Derecognition of lease liability 388 0 0
Derecognition of right-of-use asset (85) 0 0
Foreign withholding tax paid 0 (480) (37)
Other operating income and expenses 5,308 3,053 2,570
Finance (costs)/gains      
Remeasurement of borrowing arrangements (1,965) (416) (2,351)
Interest expense (19,872) (21,753) (20,658)
Facility fee (2,002) (799) 0
Total Finance costs (23,839) (22,968) (23,009)
Loss before income tax $ (56,887) $ (101,812) $ (88,147)